Herbalist and health researcher Djehuty Ma’at-Ra shares his personal views, beliefs, opinions, knowledge and research on the subject of chemotherapy as a modality for cancer. For the best in all natural herbal remedies and natural products, visit www.dhealthstore.com.
The time you spend with your doctor is valuable, but it is sometimes hard to know how to get the most out of your visit. We are honored to have Dr. Robert Arnold offer ways we can better discuss our treatment and general health issues with our doctors. We appreciate Dr. Arnold’s contribution of her time, Magee Womens Hospital of UPMC for providing the resources to make this lecture series possible and to Gilda’s Club for providing the venue.
There have been many genetic discoveries concerning cancer and only a few have been applied to ovarian cancer, specifically. We were fortunate to have Dr. Kristin Zorn speak to us about her exciting research into the genetic risk for ovarian cancer as well as the overall findings related to this topic. We appreciate Dr. Zorn’s contribution of her time and Magee Womens Hospital of UPMC for providing the resources to make this lecture series possible.
We know that the topic of recurrence in cancer patients can be an overwhelming and scary issue for any ovarian cancer survivor. In this video, Dr. John Comerci leads a discussion on recurrence and openly answered many questions from our survivor audience — hopefully yours will be one of them. We appreciate Dr. Comerci’s contribution of his time and Magee Womens Hospital of UPMC for providing the resources to make this lecture series possible.
www.facebook.com Kathy McAfee shares her experiences fighting ovarian cancer, surgery and chemotherapy with TV host Jim Pellegrino of The Hour. She claims that a positive attitude was a healing force in her treatment, as was creativity and a large network of supportive friends and family
Ovarian cancer typically occurs in women ages 55 years and older. Women who start conceiving at a younger age and have multiple children are at a lower risk of developing ovarian cancer. There is an increased incidence seen with a prior history of breast cancer or family history of breast and ovarian cancer, as well as in women who take estrogen-only hormone replacement for more than 5 years. Birth control pills have been shown to decrease the incidence of ovarian cancer by as much as 50% when taken for a duration of one year or more. Suppression of ovulation events appears to be the link in prevention for both women with multiple pregnancies and ovulation suppressing birth control methods. This may be related to the increased risk for sequential cumulative mutations that may occur with cell division, stimulated within the skin of the ovary at ovulation. Surgical intervention is the definitive treatment especially in early stage ovarian cancer. For more advanced stages surgery with chemotherapy is standard, including combinations of drugs for six or more infusion cycles. Chemotherapy infusions may be administered using an intravenous line or durable venous access port commonly referred to as a ‘Port-a-cath’. Alternatively, in selected cases, chemotherapy may be administered directly in to the abdominal cavity utilizing an intra-peritoneal ‘Port-a-cath’ placed at the time of surgery, as demonstrated here. When a pelvic mass is demonstrated (identified by ultrasound, CT …